Urszula B. C.
- Country
- Poland
- Department
- n/a
Research Overview
- A Phase 3b Long-term Efficacy and Safety Extension Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria
- Efficacy and Safety of Barzolvolimab in Patients with Chronic Spontaneous Urticaria Symptomatic Despite H1 Antihistamine Treatment: A Phase 3 Randomized, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 65 of 158 partner sites.
Specializations
Dermatological Research
The investigator specializes in studying chronic spontaneous urticaria, focusing on advanced therapeutic approaches for managing this challenging skin condition.
- Urticaria Management
- Novel Biological Therapies
- Chronic Skin Conditions
Their research centers on evaluating innovative treatments for patients with persistent urticaria symptoms, particularly examining therapeutic efficacy in reducing disease activity.
Immunological Studies
The investigator conducts research in immune-mediated skin disorders, with particular attention to the mechanisms underlying chronic urticaria development.
- Immunological Response
- Autoimmune Conditions
- Treatment Resistance
Their work involves assessing therapeutic interventions that target specific immune pathways in chronic urticaria patients.
Clinical Assessment
The investigator focuses on developing and implementing clinical measurement tools for evaluating treatment effectiveness in chronic urticaria.
- Disease Activity Monitoring
- Treatment Response Assessment
- Patient Outcome Measures
Their expertise includes utilizing standardized scoring systems to evaluate urticaria activity and treatment efficacy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.